Search Results - "Weenink, B."

Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial by Gao, Y., Weenink, B., van den Bent, M.J., Erdem-Eraslan, L., Kros, J.M., Sillevis Smitt, PAE, Hoang-Xuan, K., Brandes, A.A., Vos, M., Dhermain, F., Enting, R., Ryan, G.F., Chinot, O., Ben Hassel, M., van Linde, M.E., Mason, W.P., Gijtenbeek, J.M.M., Balana, C., von Deimling, A., Gorlia, Th, Stupp, R., Hegi, M.E., Baumert, B.G., French, P.J.

“…The European Organisation for Research and Treatment of Cancer (EORTC) 22033-26033 clinical trial (NCT00182819) investigated whether initial temozolomide (TMZ)…”
Get full text

P09.04 Adoptive T cell therapy for IDH1R132H-mutated low-grade glioma by Weenink, B., van Brakel, M., Wijers, R., Klaver, Y., Belcaid, Z., Berrevoets, C., Sillevis Smitt, P., French, P., Debets, R.

Get full text

Environmental Policy and the Greenhouse Effect by Weenink, J. B.

“…Emissions, resulting from human activity, are substantially increasing the atmospheric concentration of greenhouse gases. This, in turn, is causing an…”
Get full text

Environmental policy and the greenhouse effect by WEENINK, J. B

Get full text